文献速递围术期管理与 ERAS

OPCABG术前停用阿司匹林与氯吡格雷对术后出血及输血的影响

[Impact of discontinuation of aspirin and clopidogrel before off-pump coronary artery bypass grafting on postoperative bleeding and transfusion requirement].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2019-01-01

该回顾性研究分析353例OPCABG患者,比较三种抗血小板停药方案。结果显示术前停用阿司匹林者术后12小时胸腔引流量低于指南推荐组,但输血率及12小时后引流量无差异;停用氯吡格雷≤5天不增加出血及输血,且围术期心律失常发生率更低。

要点

  • 术前停用阿司匹林可减少OPCABG术后12小时胸腔引流量。
  • 停用氯吡格雷≤5天不增加术后出血及输血需求。
  • 停用氯吡格雷≤5天者围术期心律失常发生率显著低于指南组。

核心结论

  • 停用阿司匹林者术后12小时胸腔引流量低于指南推荐组,但输血率及12小时后引流量无差异。
  • 停用氯吡格雷≤5天者术后引流量和输血需求与指南组相似,但围术期心律失常发生率更低。

研究设计与样本

  • 回顾性分析2017年1月至2018年1月复旦大学附属中山医院心外科353例接受OPCABG的患者。
  • 男性268例,女性85例,年龄(66.0±9.1)岁。
  • 分为指南推荐组(不停阿司匹林,停氯吡格雷>5天)、不停药组(不停阿司匹林,停氯吡格雷≤5天)、停药组(停阿司匹林,停氯吡格雷>5天)。

主要发现

  • 指南推荐组、不停药组、停药组术后12小时胸腔引流量分别为280(153)ml、291(229)ml、225(161)ml。
  • 指南推荐组与不停药组术后12小时引流量无显著差异(P=0.865),红细胞输血率(χ²=2.626,P=0.149)和血浆输血率(χ²=1.258,P=0.324)也无显著差异。
  • 术后12小时开始服用双联抗血小板药物后,引流量随时间变化趋势在指南推荐组与不停药组间(F=0.019,P=0.941)及与停药组间(F=2.447,P=0.113)均无显著差异。
  • 指南推荐组围术期心律失常发生率显著高于不停药组(4.8%比0,χ²=5.073,P=0.038)。

临床怎么用

  • OPCABG术前停用阿司匹林可考虑用于减少术后早期胸腔引流量,但需权衡缺血风险。
  • 术前停用氯吡格雷≤5天未增加出血及输血需求,且可能与更低的心律失常发生率相关。

局限性

  • 本研究为单中心回顾性分析,样本量有限,结论需前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the influence of different discontinuation time of aspirin and clopidogrel before off-pump coronary artery bypass grafting (OPCABG) on postoperative bleeding and blood products transfusion requirement. Methods: Three hundred and fifty-three coronary artery disease patients who underwent OPCABG from January 2017 to January 2018 at Department of Cardiac Surgery, Zhongshan Hospital, Fudan University were retrospectively analysed. There were 268 males and 85 females, aged (66.0±9.1)years. All patients were divided into three groups: (1) guideline-recommended group: patients who discontinued clopidogrel for >5 days without discontinuing aspirin before surgery; (2) without discontinuing group: patients who discontinued clopidogrel for ≤5 days without discontinuing aspirin before surgery; (3) discontinuing group: patients who discontinued clopidogrel for >5 days with discontinuing aspirin before surgery. Postoperative bleeding recorded as chest tube drainage (CTD) volume and blood products transfusion requirement and perioperative complications were recorded. CTD volumes within 12 hours after surgery between groups were compared by Mann-Whitney U tests, CTD volumes after 12 hours postoperatively were compared by repeated measures analysis of variance and blood products transfusion and complications incidence were compared by χ(2) test or Fisher's precise test. Results: The 12 hours CTD volumes of guideline-recommended group, without discontinuing group, discontinuing group after surgery were 280(153) ml (M(Q(R))), 291(229) ml, 225(161) ml, respectively. There were no significant differences in postoperative 12 hours CTD volumes (P=0.865), red blood cells transfusion incidence (χ(2)=2.626, P=0.149) and fresh frozen plasma (FFP) transfusion incidence (χ(2)=1.258, P=0.324) between guideline-recommended group and without discontinuing group. However, the 12 hours CTD volumes were significantly higher in guideline-recommended group patients compared with disconutinuing group patients (U=5 247, P=0.002). No significant differences were observed in red blood cells (χ(2)=0.182, P=0.757) and FFP (χ(2)=0.083, P=0.839) transfusion rate between these two groups. Repeated measures analysis of variance indicated that when patients began to take antiplatelet drugs (aspirin and clopidogrel) after 12 hours postoperatively, the change of CTD volumes beyond 12 hours after surgery didn't differ either between guideline-recommended group and without discontinuing group (F=0.019, P=0.941) or between guideline-recommended group and discontinuing group (F=2.447,P=0.113). Besides, the incidence of perioperative arrhythmia was significantly higher in guideline-recommended group patients compared with without discontinuing group patients (4.8% vs. 0, χ(2)=5.073, P=0.038). Conclusions: OPCABG patients who discontinued aspirin before surgery had lower postoperative 12 hours CTD volumes but similar blood products transfusion rate and CTD volumes beyond 12 hours postoperatively compared with patients adhering to the current guideline-recommended protocol. And for patients who discontinued clopidogrel for ≤5 days, postoperative CTD volumes and blood products transfusion requirement were similar but the incidence of perioperative arrhythmia was significantly lower compared with guideline-treated patients. 目的: 探讨阿司匹林和氯吡格雷的停药时间对行不停跳冠状动脉旁路移植术(OPCABG)患者术后出血及输血的影响。 方法: 回顾性分析2017年1月至2018年1月353例在复旦大学附属中山医院心外科接受OPCABG的患者的临床资料。男性268例,女性85例,年龄(66.0±9.1)岁。将患者分为三组:(1)指南推荐组:术前不停用阿司匹林,但停用氯吡格雷>5 d;(2)不停药组:术前不停用阿司匹林,且停用氯吡格雷≤5 d;(3)停药组:术前停用阿司匹林,且停用氯吡格雷>5 d。记录术后不同时间胸腔引流量、输血量及围手术期并发症的情况。利用Mann-Whitney U检验比较患者术后12 h胸腔引流量差异,重复测量方差分析比较患者术后36、60、84 h胸腔引流量变化情况,χ(2)检验或Fisher确切概率法分析输血及并发症发生率的差异。 结果: 指南推荐组、不停药组、停药组术后12 h胸腔引流量[M(Q(R))]分别为280(153)ml、291(229)ml、225(161)ml。指南推荐组与不停药组相比,术后12 h胸腔引流量无明显差异(P=0.865),红细胞、血浆输注量也无明显差异(χ(2)=2.626,P=0.149;χ(2)=1.258,P=0.324)。指南推荐组与停药组相比,术后12 h胸腔引流量更高(U=5 247,P=0.002),但红细胞计数、血浆输注量无明显差异(χ(2)=0.182,P=0.757;χ(2)=0.083,P=0.839)。当患者在术后12 h开始服用双联抗血小板药物后,不停药组与指南推荐组胸腔引流量随时间变化的趋势无明显差异(F=0.019,P=0.941),停药组与指南推荐组相比也无明显差异(F=2.447,P=0.113)。指南推荐组患者围手术期心律失常发生率高于不停药组患者(4.8%比0,χ(2)=5.073,P=0.038)。 结论: 对于拟行OPCABG的患者,与目前国内指南推荐方案相比,术前停用阿司匹林会减少术后12 h胸腔引流量,但对输血量及12 h后引流变化情况无影响;术前停用氯吡格雷≤5 d不会增加术后12 h胸腔引流量及输血量,同时可能降低围手术期心律失常发生率。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang Z, Xia LM, Song K, et al. [Impact of discontinuation of aspirin and clopidogrel before off-pump coronary artery bypass grafting on postoperative bleeding and transfusion requirement]. Zhonghua Wai Ke Za Zhi. 2019. PMID: 30861647. doi:10.3760/cma.j.issn.0529-5815.2019.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。